Cargando…
Comparison of the tumor cell secretome and patient sera for an accurate serum-based diagnosis of pancreatic ductal adenocarcinoma
Pancreatic cancer is the currently most lethal malignancy. Toward an accurate diagnosis of the disease in body liquids, we studied the protein composition of the secretomes of 16 primary and established cell lines of pancreatic ductal adenocarcinoma (PDAC). Compared to the secretome of non-tumorous...
Autores principales: | Mustafa, Shakhawan, Pan, Longqiang, Marzoq, Aseel, Fawaz, Malak, Sander, Laureen, Rückert, Felix, Schrenk, Andrea, Hartl, Christina, Uhler, Rico, Yildirim, Adem, Strobel, Oliver, Hackert, Thilo, Giese, Nathalia, Büchler, Markus W, Hoheisel, Jörg D, Saeed, Mohamed Saiel Alhamdani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355318/ https://www.ncbi.nlm.nih.gov/pubmed/28060763 http://dx.doi.org/10.18632/oncotarget.14449 |
Ejemplares similares
-
Impact of the secretome of activated pancreatic stellate cells on growth and differentiation of pancreatic tumour cells
por: Marzoq, Aseel J., et al.
Publicado: (2019) -
Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
por: Zhang, Chaoyang, et al.
Publicado: (2023) -
Clinical proteomics: Promises, challenges and limitations of affinity arrays
por: Betzen, Christian, et al.
Publicado: (2015) -
Promoter Hypermethylation Promotes the Binding of Transcription Factor NFATc1, Triggering Oncogenic Gene Activation in Pancreatic Cancer
por: Wu, Yenan, et al.
Publicado: (2021) -
SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosis
por: Manoochehri, Mehdi, et al.
Publicado: (2020)